Huemer, F; Weiss, L; Regitnig, P; Winder, T; Schmitt, CA; Thaler, J; Wöll, E; Greil, R.
Comment on: Incidence, clinicopathological features, and clinical outcomes of low HER2 expressed, inoperable, advanced, or recurrent gastric/gastroesophageal junction adenocarcinoma.
ESMO Open. 2024; 9(4): 102973
Doi: 10.1016/j.esmoop.2024.102973
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG